Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vectorspace AI is an AI and data-engineering company that applies natural language processing, feature-vector generation, and hidden-relationship discovery to financial and life sciences datasets. In healthcare and biosciences, the company operates through Vector Space Biosciences, which is developing a platform that combines biological CubeSat experiments, biomedical data integration, and language-model-based analytics to generate novel hypotheses for drug discovery, drug repurposing, and precision medicine. The company appears to be primarily a platform and data-services business rather than a traditional therapeutics developer with named clinical assets. Its published biosciences focus centers on countermeasures for biological damage associated with microgravity and radiation exposure during spaceflight, with potential terrestrial applications. Vectorspace AI also markets financial analytics products built on similar vector-based data engineering techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vectorspace AI.